Author:
Will B.P,Berthelot J.-M,Nobrega K.M,Flanagan W,Evans W.K
Reference26 articles.
1. The cost of combined modality interventions for Stage III non-small cell lung cancer;Evans;J. Clinical Oncol.,1997
2. The cost-effectiveness of Navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in Stage IV non-small cell lung cancer;Evans;Eur. J. Cancer,1996
3. An estimate of the cost effectiveness of gemcitabine in Stage IV non-small cell lung cancer;Evans;Semin. Oncol.,1996
4. Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small cell lung cancer;Earle;Br. J. Cancer,1999
5. Berthelot J-M, Will BP, Houle C, Earle C, Evans WK. An Economic Evaluation of Screening and Treatment of Pre-clinical Lung Cancer. Oral presentation, 14th Annual Meeting of the International Society of Technology Assessment in Health Care, Ottawa, 1998 (abstr 101).
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献